Call for Abstract

Pharmaceutics & Novel Drug Delivery Summit China, will be organized around the theme “”

Pharmaceutics China 2020 is comprised of 12 tracks and 36 sessions designed to offer comprehensive sessions that address current issues in Pharmaceutics China 2020.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

It’s the study of how a human body react differently against drugs and drug therapies, these changes are determined by the human genetic makeup or genes. This study helps drug manufacturers and providers to choose the right amount of dose for each individual patient, which is likely to work best on that patient’s body.

  • Track 1-1Polypharmacy
  • Track 1-2Drug labeling
  • Track 1-3Pharmacovigilance

Medical treatments often react differently on each patients, in this case personalized medicine helps to predict the possible reaction a patient’s body might have after the administration of drug, and customized medical treatment is provided to the patient. This method is a breakthrough treatment process but it studies the patients’ unique molecular reaction to a certain disease.

  • Track 2-1Molecular medicine
  • Track 2-2Evidence-based medicine
  • Track 2-3Precision Medicine Initiative

Pre-Formulation and Formulation aspects which is the process in which different chemical substances i.e., active chemical substances will combine together to produce a medical compound i.e., medical drug. Pharmaceutical Formulations include Ophthalmic Formulation, Paediatric Formulation Development, Topical Formulation and Medication Formulation.

  • Track 3-1Pharmaceutics
  • Track 3-2Galenic formulation
  • Track 3-3Dosage form

Noticing  drug targets plays essential roles in designing novel drugs and combating diseases. Unfortunately, our current knowledge about drug targets is far from comprehensive. In the past decade, the collection of various types of study of science related data makes it possible to develop computational approaches to predict drug targets.

  • Track 4-1Targeted drug delivery
  • Track 4-2DrugBank
  • Track 4-3Drug resistance

Drug design is the process of discovering and designing new drugs, medication based on the knowledge of the targeted molecule. The drug acts as an activator/inhibitor on the biological molecule such as protein and hence in turn results in a therapeutic benefit to the affected person.

  • Track 5-1New Drug Application
  • Track 5-2Investigational New Drug
  • Track 5-3Drug nomenclature

It’s the process of designing of drug that will target the small molecules such as peptides, RNAi, protein molecules, which results in the alteration of the phenotype of a cell or an organism in the desired manner.

  • Track 6-1Reverse pharmacology
  • Track 6-2Phenotypic screening
  • Track 6-3Pharmacognosy

Advanced drug delivery technologies enhance the absorption rate of drug, efficacy and the experience of patients towards the drug.

  • Track 7-1Thin-film drug delivery
  • Track 7-2Nanoparticle drug delivery
  • Track 7-3Microneedle drug delivery

The pharmaceutical industry is growing day by day with the introduction of new technologies but still, it is facing hurdles such as skilled professionals, increase in the development cost, protecting the new innovations.

  • Track 8-1Medical research
  • Track 8-2Clinical pharmaceutical scientist
  • Track 8-3Cubist Pharmaceuticals

Nanomedicine provides clinically useful devices and research tools to the pharmaceutical industry. It initiates an advanced commercial application in the pharmaceutical industry which includes drug delivery system, in vivo imaging and many more.

  • Track 9-1Impact of nanotechnology
  • Track 9-2Nanorobotics
  • Track 9-3Virus nanotechnology

Designing a drug based on the targeted molecule and testing it for further modification, the testing of drugs is usually done by high-throughput screening (HTS).

  • Track 10-1Phenotypic screening
  • Track 10-2Virtual screening
  • Track 10-3High-throughput screening

Regulatory Affairs is involved in the development of new medicinal products from early on, by integrating regulatory principles and by preparing and submitting the relevant regulatory dossiers to health authorities. Regulatory Affairs is involved in every step of the development of a novel medicine and in the post-marketing activities with medicinal products.

  • Track 11-1Regulatory science
  • Track 11-2Dosage form
  • Track 11-3Thin-film drug delivery

The application of biomaterials in the drug delivery system has overcome the limitation we were facing in delivering drugs. It has increased the bioavailability at the site, reducing the side effect of drugs.

  • Track 12-1Colloidal gold
  • Track 12-2Hydrogel
  • Track 12-3Osmotic-controlled release oral delivery system